Best At-Home Ketamine Therapy Providers Compared (2026)

Last updated: April 2026

At least ten telehealth companies now offer at-home ketamine therapy across the United States, with pricing that ranges from $87 per session to $399 per month. But comparing them is harder than it should be — every provider's website tells you why they're the best, and none of them tell you about the wrongful death lawsuit, the FDA safety warning, or the DEA rule expiration that could shut down the entire model by January 2027.

This guide compares every major at-home ketamine provider operating in 2026 with verified pricing, clinical protocol details, independent patient reviews, and the safety and regulatory context that most comparison articles leave out.

Disclaimer: Ketamine is not FDA-approved for any psychiatric indication. All at-home providers use compounded (off-label) ketamine. This guide is educational — not medical advice. Consult a healthcare provider before starting any ketamine treatment.

Quick comparison: every at-home ketamine provider in 2026

Provider	Price	Per Session	Model	Medication	States	Insurance	Sitter Required
Joyous	$129/mo	~$4.30/day	Daily microdose	Buccal troches (10–120mg)	~28	No (HSA/FSA)	No
BetterU	$500–$792	$88–$100	Macrodose sessions	Oral lozenges; nasal spray option	31–35	No (HSA/FSA)	Yes
Choose Your Horizon	From $87/session	$87+	Guided Zoom macrodose	At-home ketamine	Multi-state	Some plans	Zoom guide present
Anywhere Clinic	$150/visit	$150	Insurance-based	At-home ketamine	Multi-state	Yes	Not specified
Innerwell	$998–$2,100	$54–$137	Macrodose + psychotherapy	Rapid-dissolve tablets	31–34	Yes (CA, NY)	Yes
Mindbloom	$1,290–$2,970	$129–$215	Bi-weekly macrodose	Tablets or injectable	38 + DC	No (superbills)	Yes
Wondermed	$399/mo	~$50–$100	4–8 macrodose/mo	Sublingual lozenges	12+	No (HSA/FSA)	Not specified
Nue Life	$1,399	~$233	1–2x/week macrodose	Sublingual lozenges	~15–19	No (HSA/FSA)	Yes
Dr. Pruett/Taconic	~$375/mo + $125 meds	~$254/visit	Psychiatrist-directed	Oral RDTs or IM injection	47+	No (superbills)	Varies
Isha Health	$350/mo + $50–100 meds	Varies	KAP with IFS therapy	Sublingual tablets	6+	No (HSA/FSA)	Not specified

Pricing verified from provider websites, April 2026. Prices change frequently — confirm directly before enrolling.

The per-session cost spread is significant: from $4.30/day (Joyous) to $233/session (Nue Life). But comparing these numbers directly is misleading — they represent fundamentally different treatments.

Two different treatments sharing the same name

At-home ketamine therapy is not one thing. It's two pharmacologically distinct approaches.

Daily low-dose (psycholytic) model: Only Joyous uses this approach. Patients take a small dose (10–120mg) of sublingual ketamine every day. At these doses, there's no dissociative or psychedelic experience — patients remain fully coherent. No trip sitter is needed and there's no session downtime. The rationale is that consistent low-dose exposure promotes neuroplasticity over time. No peer-reviewed clinical trials have been published on this specific daily protocol.

Session-based macrodose (psychedelic) model: Every other provider uses some version of this. Patients take a larger dose (100–800mg+) every one to two weeks, producing a dissociative or psychedelic experience lasting 45 minutes to several hours. A sitter or monitor must be present. The rationale is that the psychedelic experience itself — combined with integration therapy — drives lasting psychological change. Mindbloom has published two peer-reviewed studies using this model, covering 11,441 patients.

These aren't just different doses. They're different treatment philosophies with different evidence bases, different risk profiles, and different lifestyle demands.

Provider details

Joyous — $129/month, daily low-dose

Best for: Lowest cost, no session downtime, no sitter required.

Joyous charges $129/month (3-month commitment) or $159/month (flexible plan, drops to $129 after 3 months). Financial assistance can bring this to roughly $79–89/month. That buys 30 compounded ketamine troches per month, a free initial video consultation, daily text-based check-ins, weekly PHQ-9/GAD-7 mood assessments, monthly bladder health screening, and provider access via text and email. HSA/FSA accepted.

Treatment starts at 10–15mg and titrates upward based on daily check-in data. A New York Times investigation reported that most patients reached the maximum 120mg within weeks. At 20–25% bioavailability for sublingual dosing, that delivers roughly 24–30mg of active ketamine — well below the psychedelic threshold.

Strengths: Most affordable option by far. Daily monitoring frequency actually exceeds most competitors. Data on 45,000+ patients. No sitter needed — treatment fits into a normal day. Available in ~28 states.

Concerns: No peer-reviewed research on the specific daily low-dose protocol. Clinical communication is almost entirely text-based — patients report difficulty reaching a real person. Medication shipping delays are a recurring complaint, with patients running out for 10+ days at a time. The New York Times characterized Joyous as "the most hands-off treatment" for patients with serious mental health challenges. One legal inquiry (2023) from a patient alleging Joyous-prescribed ketamine caused psychosis, though no formal lawsuit was found.

Independent reviews: Trustpilot 4.0/5 (1,081 reviews). Consistent pattern: medication effectiveness and affordability praised; customer service, shipping reliability, and cancellation process criticized.

States: ~28 (AZ, CA, CO, CT, FL, IA, IL, IN, MA, ME, MI, MO, MT, NJ, NV, NY, OH, OR, PA, SD, TN, TX, UT, VT, WA, WI, WY). Notably absent from GA, VA, MD, NC, MN.

BetterU — $88–$100/session, best macrodose value

Best for: Affordable macrodose treatment, veterans/first responders (discounts available), patients who want a nasal spray option.

BetterU charges $100/session for the 5-session Introduction package ($500 total) or $88/session for the 9-session Transformation package ($792 total). Returning clients pay $100/session. Financing through Affirm brings monthly payments to roughly $45–54. Discounts available for veterans, teachers, and first responders.

The included "Brain Box" starter kit has a blood pressure cuff, meditation mask, heart diffraction glasses, and journal. Integration coaching uses their "Neuroplastic Therapy" program rooted in CBT and psychodynamic approaches. BetterU is also the only at-home provider offering an in-person nasal spray option at their office locations. Virtual peer support by a registered nurse is available for an additional $59/session. The clinical team includes physicians trained at Stanford, Harvard, and Johns Hopkins.

Strengths: Most affordable macrodose option. Strongest independent review profile of any provider researched. Broad state coverage (31–35 states). Unique nasal spray option. Full refund plus complimentary psychiatric evaluation if deemed inappropriate for treatment.

Concerns: The $59/session virtual sitter cost isn't always disclosed upfront. Some reports of mid-treatment price increases. No published peer-reviewed outcome data.

Independent reviews: Trustpilot 4.5/5 (393 reviews) with the vast majority giving 5 stars — the strongest independent review profile of any provider researched. Patients consistently praise affordability and staff compassion.

States: 31–35 (AK, AZ, CA, CO, CT, FL, GA, ID, IL, IN, IA, LA, MD, MA, MI, MN, MO, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, TN, TX, UT, VA, WA, WI).

Innerwell — $54–$137/session, most clinical oversight, accepts insurance

Best for: Patients prioritizing clinical quality, anyone with qualifying insurance in California or New York.

Innerwell is the only major at-home provider staffed by licensed psychiatric clinicians and Master's/Doctoral-level psychotherapists certified in ketamine-assisted psychotherapy. Psychotherapy is included as standard in both programs — not an add-on. EMDR therapy is available as an additional option.

Self-pay pricing: Foundation program (8 doses) is $1,098 ($137/session) or $998 paid upfront. Extended program (24 doses) is $2,100 ($88/session) or $2,000 upfront. With insurance (Aetna, Cigna, UnitedHealthcare, BCBS in CA and NY): Foundation drops to $599 ($75/treatment), Extended to $1,299 ($54/treatment). Continuing care runs $88–$200/session depending on frequency. FSA/HSA accepted.

Innerwell uses a proprietary dosing algorithm based on body weight, psychiatric history, and comfort level, with doses ranging 100–800mg. They also partner with Enthea to offer ketamine therapy as an employer-sponsored workplace benefit.

Strengths: Licensed clinicians (not coaches or guides). Psychotherapy included. One of very few providers accepting insurance. Dosing algorithm accounts for individual variation. Reports 87% patient improvement within 4 weeks (internal data).

Concerns: Very limited independent review data — only about 6 Trustpilot reviews (3.4/5). Not enough to assess patient experience at scale. One complaint about opaque billing structure (monthly charges continuing when medication hasn't shipped). Insurance coverage limited to two states.

States: ~31–34. Insurance most robust in CA and NY.

Mindbloom — $129–$215/session, largest provider, facing lawsuits

Best for: Widest state coverage, published clinical research, injectable ketamine option.

Mindbloom is the largest at-home ketamine provider, claiming over 700,000 clinician-supervised sessions across 38 states plus DC. The treatment model is bi-weekly macrodose sessions with sublingual tablets or subcutaneous injectables (launched January 2025), an eye mask, curated soundscapes, and a required Peer Treatment Monitor (trusted adult) physically present.

Current new client pricing: $215/session for 6 sessions ($1,290), $185/session for 12 ($2,220), $165/session for 18 ($2,970). Returning clients get lower rates, especially for injectables. Programs include medication, the "Bloombox" kit (eye mask, blood pressure cuff, journal), 2–4 clinician consults, 3–5 guide coaching sessions with unlimited messaging, daily group integration circles, and the Mindbloom app. HSA/FSA accepted; superbills provided.

The January 2025 injectable launch introduced at-home subcutaneous self-injection using small insulin needles. Mindbloom reports 81% of pilot clients preferred injectables over tablets. The move generated significant industry controversy over the safety implications of unsupervised self-injection of a controlled substance with higher bioavailability than oral forms.

Active lawsuits:

A wrongful death lawsuit was filed in October 2025 in North Carolina. Phillip Ward, 27, died on October 29, 2023 from ketamine toxicity with blood ketamine levels of 9.3 mg/L. According to the lawsuit, Ward had disclosed to Mindbloom that he was already receiving medically supervised Spravato treatments, had a history of substance use disorder, and had hypertension. A clinician initially flagged him for additional requirements, but the suit alleges these conditions were never verified. Ward missed multiple mandatory appointments and had failed subscription payments, but was never discontinued from treatment. His blood pressure cuff was found unused in its original packaging. The case is ongoing.

Separately, Mindbloom filed an $88 million defamation lawsuit against the Wall Street Journal in June 2025, alleging a 2024 article falsely implied a connection between Mindbloom and Matthew Perry's death. Perry was never a Mindbloom client. Mindbloom claims the article caused a halving in new client sales. WSJ has called the suit "misguided" and "meritless." The case is ongoing.

Strengths: Two published peer-reviewed studies (largest covering 11,441 patients) — more clinical evidence than any other at-home provider. Broadest state coverage (38 + DC). Most established brand in the space. Injectable option for patients who don't respond well to oral dosing.

Concerns: The wrongful death lawsuit alleges serious clinical protocol failures — flagged contraindications that were never followed up, mandatory appointments missed without the patient being discontinued, and monitoring equipment that was shipped but found unused. Price has increased (the 6-session program was previously $954–$1,176). Billing confusion and cancellation difficulties are persistent complaints. Guide quality varies. After the first session, subsequent sessions are self-administered.

Independent reviews: Self-reported 4.7/5 (500+ reviews). Innerbody editorial rating: 3.9/10. Reddit sentiment mixed — transformative experiences balanced against cost, billing, and oversight concerns.

States: 38 + DC (tablets); 29 states (injectables).

Nue Life — $233/session, premium with uncertain trajectory

Best for: Tech-forward patients who value app integration and holistic programming.

Nue Life charges $1,399 for 6 sessions, making it the most expensive per-session option. The price buys a sophisticated companion app with musicologist-curated playlists, voice journaling, Apple Watch biometric integration, and a "Nue Score" progress metric. Unlimited prep/integration group sessions and individual health coaching are included.

The company was acquired by Beckley Waves in October 2023 and has since contracted its state footprint from 23 to roughly 15–19. Multiple patients report being dropped from service when Nue Life withdrew from their state. Glassdoor reviews (2.4/5 from 36 employees) suggest internal instability.

Independent reviews: Trustpilot 3.2/5 (64 reviews). BBB "B-" rating. Positive on healing experiences and coaching quality; negative on disorganization, communication, and refunds.

States: ~15–19 and apparently shrinking.

Wondermed — $399/month, AI-powered, limited coverage

Wondermed charges $399/month for 4–8 macrodose sessions with a proprietary AI platform, "WonderFlow" curriculum, and musicologist-produced soundscapes. Also offers "Wonder Relief" for chronic pain. Available in only ~12 states and has essentially no independent review presence — no Trustpilot, no BBB rating, minimal Reddit discussion.

Dr. Pruett / Taconic Psychiatry — Board-certified psychiatrist, 47+ states

A fundamentally different model from the platform-based providers. Dr. Pruett is a board-certified psychiatrist who personally manages every patient — no coaches, no guides, no care coordinators. Treatment integrates ketamine with full psychiatric care including psychodynamic therapy, CBT, ERP, and medication management. Licensed in 47+ states (all except SC, AR, PA), the widest individual practitioner coverage.

Cost: $450 initial appointment, $250 follow-ups, ~$125/month medication from Empower Pharmacy. Roughly $375/month ongoing — less than Wondermed and comparable to Mindbloom when factoring in the psychiatrist-level care included. The Ketamine Saved Me! community recommends Dr. Pruett as a top option for patients wanting physician-directed care.

Other active providers

Choose Your Horizon — Starting at $87/session (potentially the lowest per-session cost). Guided Zoom sessions. May accept some insurance. Limited independent review data.

Anywhere Clinic — $150/visit, insurance-based model. Led by Dr. Sam Zand, D.O. (Johns Hopkins trained, previously BetterU's CMO). Multi-state telehealth.

Isha Health — $350/month consultations + $50–100/month medication. KAP-trained clinicians using Internal Family Systems therapy. Available in CA, FL, CO, NY, WA, AZ.

Noma Therapy — Was the first at-home KAP provider accepting Medicaid, Medicare, and commercial insurance. However, their website currently states they're no longer accepting new patients.

Kalm Health — Newer entrant advertising "most affordable at-home ketamine therapy" with a price-match guarantee. Limited public pricing data.

Confirmed closed: Peak (September 2022), Smith Family MD (DEA suspension, May 2023), KetaMD (acquired and shelved, August 2022).

Safety and regulatory context

The FDA's position

The FDA's October 2023 safety alert warns that using compounded ketamine at home without provider monitoring "may put patients at risk for serious adverse events." The alert cites a case where a patient's blood ketamine reached approximately twice the level used for general anesthesia after taking compounded oral ketamine at home. Risks highlighted: respiratory depression, blood pressure spikes, psychiatric worsening, abuse and misuse potential, and bladder damage.

Every provider on this list operates under this warning. None have FDA approval for their specific protocols.

The DEA telemedicine cliff: December 31, 2026

The entire at-home ketamine model depends on COVID-era exceptions to the Ryan Haight Act, which normally requires an in-person evaluation before prescribing controlled substances via telemedicine. These flexibilities are on their fourth temporary extension, expiring December 31, 2026.

If they lapse without permanent rules, new patients would need an in-person visit before receiving a ketamine prescription — fundamentally breaking the telehealth-only model. Over 7 million controlled substance prescriptions were issued via telemedicine without prior in-person visits in 2024. A proposed rule from the Biden administration would create a permanent framework, but the current administration has not moved to finalize it.

This is the single biggest structural risk for every provider listed. Anyone starting at-home ketamine therapy should understand the model may not exist in its current form past 2026.

What the Reddit safety data shows

A March 2026 STAT News investigation analyzed six months of Reddit posts and described at-home ketamine patients managing severe side effects through crowdsourced advice rather than medical guidance — comparing contradictory instructions from different providers and self-adjusting doses.

A related peer-reviewed study (MDPI Behavioral Sciences, March 2026) analyzed 12,852 comments from r/TherapeuticKetamine. Key findings: 70% of reported doses exceeded 149mg, self-reported prescription doses ranged from 50mg to 800mg (a 16-fold variance), and many users interpreted dissociation and hallucinations as positive rather than recognizing potential danger signs.

The Matthew Perry effect

Matthew Perry's October 2023 death from ketamine toxicity — and the subsequent federal prosecution of five individuals, including a physician sentenced to 30 months in prison — has reshaped regulatory attitudes. The DEA has publicly compared the ketamine industry to the early days of the opioid epidemic. Poison control data shows ketamine-related exposures doubled from 205 in 2019 to 414 in 2023. A December 2025 review in the Journal of Medical Regulation described the market as a "wild west" that grew from fewer than 100 clinics in 2015 to over 1,500 by 2024.

How clinical oversight actually differs

The term "at-home ketamine therapy" covers a wide spectrum of medical supervision:

Highest oversight: Dr. Pruett/Taconic (board-certified psychiatrist on every case, integrated psychiatric care), Innerwell (licensed psychotherapists certified in KAP, available during sessions), Isha Health (KAP-trained clinicians, IFS therapy).

Moderate oversight: Mindbloom (first session guided by video, subsequent sessions self-administered with peer monitor, 2–4 clinician consults per program), BetterU (virtual clinical appointments, BP logging, 24/7 text support), Nue Life (medical consultation, optional virtual sitter at extra cost).

Lower oversight: Joyous (daily dosing with text-based check-ins, weekly digital assessments, no sitter or real-time monitoring), Wondermed (AI-supported, self-led sessions).

The Ward wrongful death case illustrates why the gap between stated protocols and actual enforcement matters. According to the lawsuit, Mindbloom's screening flagged specific contraindications that were never followed up, mandatory appointments were missed without the patient being discontinued, and monitoring equipment was shipped but found unused. Prospective patients should ask any provider not just what their protocols are, but how they enforce them when patients don't comply.

How to choose

If cost is the primary constraint: Joyous ($129/month) is unmatched for daily treatment. BetterU ($88–100/session) and Choose Your Horizon ($87/session) offer the best macrodose value.

If clinical quality is the priority: Innerwell (licensed therapists, included psychotherapy) or Dr. Pruett/Taconic (board-certified psychiatrist, personal care).

If insurance is available: Innerwell (commercial insurance in CA and NY), Anywhere Clinic (insurance-based model).

If the psychedelic experience is the goal: Any macrodose provider — BetterU, Mindbloom, Innerwell, Nue Life, or Wondermed. The daily Joyous model does not produce psychedelic effects.

If in-clinic treatment seems like a better fit: At-home ketamine isn't the only option. In-clinic IV infusion provides real-time medical monitoring, adjustable dosing, and higher bioavailability — at higher cost ($400–$800/session). For in-clinic pricing data from 600+ verified clinics across the US, see our ketamine therapy cost guide. To find providers nearby, browse the Psychedelic Beacon clinic directory.

Frequently asked questions

What is the cheapest at-home ketamine therapy? Joyous offers the lowest monthly cost at $129/month for daily low-dose treatment. For macrodose sessions, Choose Your Horizon starts at $87/session and BetterU charges $88–100/session. With insurance, Innerwell drops to $54/treatment in California and New York.

Is Mindbloom safe? Mindbloom has published two peer-reviewed studies and claims over 700,000 supervised sessions. However, the company faces a wrongful death lawsuit alleging clinical protocol failures that contributed to a 27-year-old patient's death from ketamine toxicity. Mindbloom also faces an $88 million defamation suit against the Wall Street Journal. Both cases are ongoing. Prospective patients should weigh the published research against the serious questions the lawsuit raises about protocol enforcement.

What's the difference between Mindbloom and Joyous? They use fundamentally different treatment models. Joyous provides daily low-dose sublingual ketamine (10–120mg) at $129/month — no dissociative experience, no sitter required. Mindbloom provides bi-weekly macrodose sessions at $1,290+ per program — producing psychedelic experiences with a required peer treatment monitor present.

Is at-home ketamine therapy FDA-approved? No. Ketamine is not FDA-approved for any psychiatric indication. All at-home providers use compounded (off-label) ketamine. Spravato (esketamine nasal spray) is the only FDA-approved ketamine-related treatment for depression, and it must be administered in a certified healthcare setting.

Does insurance cover at-home ketamine therapy? Most providers do not accept insurance. Innerwell accepts commercial insurance (Aetna, Cigna, UnitedHealthcare, BCBS) in California and New York. Anywhere Clinic operates an insurance-based model. Most providers accept HSA/FSA funds and provide superbills for potential out-of-network reimbursement.

What happens to at-home ketamine if the DEA telemedicine rules expire? The COVID-era telemedicine flexibilities allowing ketamine prescribing without an in-person visit expire December 31, 2026. If they lapse without permanent rules, new patients would need an in-person evaluation first — fundamentally changing how every at-home provider operates.

Which at-home ketamine provider has the best reviews? BetterU has the strongest independent review profile at 4.5/5 on Trustpilot across 393 reviews. Joyous has the highest review volume (1,082 reviews) at 4.0/5. Mindbloom self-reports 4.7/5 but has fewer independent reviews. Innerwell has very limited review presence (6 Trustpilot reviews).

Pricing and availability data verified from provider websites in April 2026. This guide will be updated as providers change pricing, expand or contract coverage, or as regulatory developments occur. For in-clinic ketamine therapy options, see our cost guide and provider directory.

Best At-Home Ketamine Therapy Providers Compared (2026) | Psychedelic Beacon